Aflac/$AFL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Aflac

Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Ticker

$AFL

Primary listing

NYSE

Industry

Insurance

Employees

12,694

ISIN

US0010551028

Aflac Metrics

BasicAdvanced
$57B
16.31
$6.44
0.83
$2.16
2.21%

What the Analysts think about Aflac

Analyst ratings (Buy, Hold, Sell) for Aflac stock.

Bulls say / Bears say

Aflac's U.S. segment experienced a 3.5% year-over-year increase in sales, driven by strong performance in group life, disability, and dental segments. (TipRanks)
The company maintains high persistency rates, with 93.8% in Japan and 79.3% in the U.S., indicating strong customer retention and business stability. (TipRanks)
Aflac's solid financial position, supported by a strong cash balance and substantial cash flow, enables the company to pursue growth initiatives and engage in prudent capital deployment through share repurchases and dividend payments. (Yahoo Finance)
Aflac's fourth-quarter earnings revealed an EPS of $1.56, missing analyst expectations of $1.62, leading to a 4% decline in share price. (Investing.com)
Net earnings per diluted share were significantly impacted by net investment losses, contrasting with gains in the previous year. (TipRanks)
Aflac Japan's net and earned premiums declined by 5% and 1.4%, respectively, due to deferred profit liability and reinsurance impacts. (TipRanks)
Data summarised monthly by Lightyear AI. Last updated on 27 Jun 2025.

Aflac Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Aflac Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AFL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs